Viewing nowDiabic Extended Release Tablet (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

MFDS item code 200607770 · Notified 2006.09.04 · Insurance code 645700720
Treatment of type 2 diabetes mellitus in adults
This medication is used to assist in blood sugar management for adults with type 2 diabetes, particularly those who are overweight, when dietary and exercise regimens alone are insufficient for blood sugar control. It can be used alone or in combination with other oral hypoglycemic agents or insulin, offering the potential for effective blood sugar control. This helps to improve symptoms of diabetes and reduce the risk of complications.
The dosage should be determined individually based on efficacy and tolerability and should not exceed the recommended maximum daily dose. - The usual starting dose is 500mg of metformin hydrochloride extended-release tablets once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week. The dose may be increased to a maximum of 2000mg per day, taken with the evening meal. If glycemic control is not achieved with a maximum once-daily dose of 2000mg, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already receiving metformin tablets, the starting dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At treatment initiation and during dose adjustment, fasting blood glucose should be measured to assess the therapeutic response and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with stage 3a moderate renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be closely monitored every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73m2, respectively, treatment with this medicine should be discontinued immediately.
This medication can rarely cause a serious condition called lactic acidosis. Lactic acidosis occurs when there is an excessive accumulation of lactic acid in the body and can be life-threatening in severe cases. Caution is required when using this medication with other diabetes treatments, as hypoglycemia may occur. It should not be administered to patients with moderate to severe renal impairment, dehydration, serious infections, or acute conditions that may affect renal function, such as acute myocardial infarction. Patients with acute and unstable heart failure or those receiving iodinated contrast agents used in certain radiological examinations should also avoid this medication. In these cases, the medication should be discontinued before and for a certain period after the tests. Do not use this medication if you have an allergy to any of its components, type 1 diabetes, diabetic ketoacidosis, severe infections, or severe liver dysfunction. Patients scheduled for surgery should stop the medication 48 hours prior and resume only after renal function has been confirmed as normal. This medication should be used cautiously in cases of irregular eating, vigorous exercise, or drug interactions, as the risk of hypoglycemia and lactic acidosis may increase. During treatment, monitoring for potential side effects such as vitamin B12 deficiency, gastrointestinal disturbances (nausea, vomiting, diarrhea), and skin rashes is important. Regular assessment of renal function is necessary to reduce the risk of drug accumulation and lactic acidosis, especially in elderly patients or those with reduced renal function, who may require dose adjustment. Alcohol consumption and acute or chronic excessive alcohol intake should be avoided due to increased risk of lactic acidosis. During pregnancy, fetal and maternal conditions should be closely monitored, and careful consideration should be given to the use of this medication during breastfeeding. It is not recommended for children as safety and efficacy have not been established. In the event of overdose, the drug can be removed through hemodialysis, so immediate consultation with medical personnel is advised if overdose is suspected. Lastly, this medication should be swallowed whole without crushing or chewing the tablets, and it is normal for the shell of the tablet to be excreted in the stool.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is best to keep the storage temperature between 1 to 30 degrees Celsius at room temperature.
White oblong tablets
30 tablets, 300 tablets (bottle)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.